NCT01710722 - The Effect of Leptin A-200, Caffeine/Ephedrine and Their Combination Upon Weight Loss and Body Composition in Man | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

February 28, 2002

Study Completion Date

February 28, 2002

Conditions

Obesity

Interventions

DRUG

caffeine and ephedrine

Caffeine 200 mg tablets and ephedrine HCl 25 mg tablets three times a day with placebo leptin A-200 subcutaneously once daily.

DRUG

Leptin A

Leptin A-200 20 mg subcutaneously once daily and placebo tablets of caffeine and ephedrine three times a day.

DRUG

caffeine, ephedrine, and leptin A

Caffeine 200 mg tablets and ephedrine HCl tablets 25 mg three times a day with leptin A-200 20 mg subcutaneously once daily.

Trial Locations (1)

Pennington Biomedical Research Center, Baton Rouge